MEDPACE HOLDINGS, INC.
MEDP · NASDAQ
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace's mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 3,400 people across 37 countries.
ESG Scores
Overall ESG3.8
Environmental7.1
Social4.7
Governance4.6
Gender Diversity
Female Directors0.16670000000000001%
Female Executives0.12396694214876033%
Women in Workforce0.67%
CEO GenderMale
Market Data
Price$622.43+2.77 (+0.45%)
Market Cap$17.35B
P/E Ratio35.31
EPS$—
52W High$677.90
52W Low$373.00
Beta1.11